Search

Your search keyword '"Hamid, Saeed"' showing total 1,364 results

Search Constraints

Start Over You searched for: Author "Hamid, Saeed" Remove constraint Author: "Hamid, Saeed"
1,364 results on '"Hamid, Saeed"'

Search Results

1. APASL clinical practice guidelines on the management of acute kidney injury in acute-on-chronic liver failure

2. Expert consensus on the diagnosis and treatment of end-stage liver disease complicated by infections

4. Ammonia is associated with liver-related complications and predicts mortality in acute-on-chronic liver failure patients

5. SAT-129 Sub-optimal global public health policies and strategies to combat hepatocellular carcinoma

6. Pharmacological investigations of newly synthesized oxazolones and imidazolones as COX-2 inhibitors

7. TransLSTM: A hybrid LSTM-Transformer model for fine-grained suggestion mining

8. Levofloxacin loaded chitosan and poly-lactic-co-glycolic acid nano-particles against resistant bacteria: Synthesis, characterization and antibacterial activity

9. Parents’ behaviour toward antibiotic self-medication in children and incidence of resistance: a cross-sectional study from Punjab, Pakistan

10. Correction: Health and economic benefits of achieving hepatitis C virus elimination in Pakistan: A modelling study and economic analysis

11. Bonemarrow Fibrosis Grade; A Useful Prognostic Marker in Myeloproliferative Neoplasms

16. HepFREEPak: protocol for a multi-centre, prospective observational study examining efficacy and impact of current therapies for the treatment of hepatitis C in Pakistan and reporting resistance to antiviral drugs: study protocol

17. Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial

18. HPLC profiling for the simultaneous estimation of antidiabetic compounds from Tradescantia pallida

19. The anticancer potential of chemical constituents of Moringa oleifera targeting CDK-2 inhibition in estrogen receptor positive breast cancer using in-silico and in vitro approches

20. An international multidisciplinary consensus statement on MAFLD and the risk of CVD

21. Identifying the early predictors of non-response to steroids in patients with flare of autoimmune hepatitis causing acute-on-chronic liver failure

22. AARC score determines outcomes in patients with alcohol-associated hepatitis: a multinational study

23. Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update

25. A Comprehensive Physiologically Based Pharmacokinetic Model for Predicting Vildagliptin Pharmacokinetics: Insights into Dosing in Renal Impairment

27. Preparation and investigation of a novel combination of Solanum nigrum-loaded, arabinoxylan-cross-linked β-cyclodextrin nanosponges for the treatment of cancer: in vitro, in vivo, and in silico evaluation

28. Determinants of anxiety and depression among university teachers during third wave of COVID-19

29. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

30. Hepatitis D virus infection: Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022

31. A global research priority agenda to advance public health responses to fatty liver disease

34. Application of a physiologically based pharmacokinetic model in predicting captopril disposition in children with chronic kidney disease

36. INASL–SAASL Consensus Statements on NAFLD Name Change to MAFLD

37. Acute variceal bleeding portends poor outcomes in patients with acute-on-chronic liver failure: a propensity score matched study from the APASL ACLF Research Consortium (AARC)

38. 17p Deletion in Patients with De Novo Acute Myeloid Leukemia and their Clinico-Haematologic Features

39. Frequency of PDGFRA, PDGFRB and FGFR1 Gene Rearrangements in Patients with Eosinophilia and Their Clinico-Haematologic Parameters

40. THU-078 Extra-hepatic organ failure in ACLF patients is associated with poor survival and limited curative therapy-results from AARC cohort

41. THU-052 Therapeutic plasma-exchange improves short-term survival in patients with ACLF admitted to intensive care unit with organ failures-a multinational AARC data analysis

42. WED-382 Modeling dual antiviral activity of lonafarnib to explain hepatitis D virus RNA negativity 24 weeks after end of therapy despite RNA positivity at end of therapy: The D-LIVR study

43. SAT-438 Fatigue is an Important Driver of Work Productivity Loss and Impairment of Patient-Reported Outcomes (PROs) among Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

44. A Comprehensive Physiologically Based Pharmacokinetic Model of Nadolol in Adults with Renal Disease and Pediatrics with Supraventricular Tachycardia

46. Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

50. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

Catalog

Books, media, physical & digital resources